Skip to nav Skip to content

Clinical Trial Search

366 Clinical Trials Found

Clinical Trial 90038

Disease Site: Other Hematopoietic
PI: Deutsch, Yehuda

Clinical Trial 22256

A Phase 3, Two-stage, Randomized, Multi-center, Controlled, Open-label Study Comparing Iberdomide Maintenance to Lenalidomide Maintenance Treatment after Autologous Stem Cell Transplantation (ASCT) in Participants with Newly Diagnosed Multiple Myeloma (NDMM)
Disease Site: Multiple Myeloma
PI: Alsina, Melissa

Clinical Trial 22483

Phase 1b/2a Study of GNS561 in Combination with Trametinib in Advanced KRAS Mutated Cholangiocarcinoma
Disease Site: Other Digestive Organ
PI: Kim, Richard

Clinical Trial 22623

Disease Site: Urinary Bladder
PI: Zhang, Jingsong

Clinical Trial 23180

Disease Site: Lung
PI: Gray, Jhanelle

Clinical Trial 23116

Disease Site: Eye and Orbit
PI: Khushalani, Nikhil

Clinical Trial 23132

A Phase 1 Study of SGN-EGFRd2 in Advanced Solid Tumors
Disease Site: Colon, Lung, Rectum
PI: Kim, Richard

Clinical Trial 23176

A Phase 2, randomised, open label, multicentre study of an intraperitoneal alpha-emitting radionuclide therapy (Radspherin®) in patients with primary advanced high-grade serous or high-grade endometrioid epithelial ovarian, fallopian tube, or primary peritoneal cancer, with peritoneal metastasis that are homologous recombination proficient and scheduled to undergo neoadjuvant chemotherapy and interval debulking surgery
Disease Site: Other Female Genital, Ovary, Reproductive System
PI: Chon, Hye Sook

Clinical Trial 23298

A Phase 2/3, Randomized, Double-Blind, Controlled Study of Zanzalintinib (XL092) in Combination with Pembrolizumab Vs Pembrolizumab in the First-Line Treatment Of Subjects with PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Disease Site: Head & Neck, Larynx, Lip, Oral Cavity and Pharynx, Squamous Cell Carcinoma (SCC)
PI: Rabinowits, Guilherme

Clinical Trial 23319

A Randomized Phase III Trial of Chemo-Immunotherapy vs Immunotherapy Alone for the Vulnerable older adult with Advanced Non-Small Cell Lung Cancer: The ACHIEVE Study
Disease Site: Lung, Non small cell lung cancer
PI: Al-Jumayli, Mohammed

Clinical Trial 23360

IFx-Hu2.0 as an Adjunctive Therapy to Pembrolizumab in Checkpoint Inhibitor Naïve Subjects with Advanced or Metastatic Merkel Cell Carcinoma
Disease Site: Other Skin
PI: Brohl, Andrew

Clinical Trial 23535

Disease Site: Lung
PI: Puri, Sonam